90 related articles for article (PubMed ID: 24558448)
21. Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons.
Loser D; Hinojosa MG; Blum J; Schaefer J; Brüll M; Johansson Y; Suciu I; Grillberger K; Danker T; Möller C; Gardner I; Ecker GF; Bennekou SH; Forsby A; Kraushaar U; Leist M
Arch Toxicol; 2021 Jun; 95(6):2081-2107. PubMed ID: 33778899
[TBL] [Abstract][Full Text] [Related]
22. Novel long-acting antagonists of muscarinic ACh receptors.
Randáková A; Rudajev V; Doležal V; Boulos J; Jakubík J
Br J Pharmacol; 2018 May; 175(10):1731-1743. PubMed ID: 29498041
[TBL] [Abstract][Full Text] [Related]
23. Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors.
Michal P; El-Fakahany EE; Doležal V
Neurochem Res; 2015 Oct; 40(10):2068-77. PubMed ID: 24821386
[TBL] [Abstract][Full Text] [Related]
24. Importance and prospects for design of selective muscarinic agonists.
Jakubík J; Michal P; Machová E; Dolezal V
Physiol Res; 2008; 57 Suppl 3():S39-S47. PubMed ID: 18481916
[TBL] [Abstract][Full Text] [Related]
25. Discovery and Development of Muscarinic Acetylcholine M
Takai K; Enomoto T
Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
[TBL] [Abstract][Full Text] [Related]
26. Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors.
Šantrůčková E; Doležal V; El-Fakahany EE; Jakubík J
PLoS One; 2014; 9(2):e88910. PubMed ID: 24558448
[TBL] [Abstract][Full Text] [Related]
27. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE
J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
[TBL] [Abstract][Full Text] [Related]
28. Classical and atypical agonists activate M1 muscarinic acetylcholine receptors through common mechanisms.
Randáková A; Dolejší E; Rudajev V; Zimčík P; Doležal V; El-Fakahany EE; Jakubík J
Pharmacol Res; 2015 Jul; 97():27-39. PubMed ID: 25882246
[TBL] [Abstract][Full Text] [Related]
29. Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.
De Lorme KC; Sikorski KL; Grant MK; El-Fakahany EE
Neurosci Lett; 2006 Dec; 410(1):11-4. PubMed ID: 17052840
[TBL] [Abstract][Full Text] [Related]
30. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
Jakubík J; El-Fakahany EE; Dolezal V
Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
[TBL] [Abstract][Full Text] [Related]
31. The M1/M4 preferring agonist xanomeline is analgesic in rodent models of chronic inflammatory and neuropathic pain via central site of action.
Martino G; Puma C; Yu XH; Gilbert AK; Coupal M; Markoglou N; McIntosh FS; Perkins MN; Laird JMA
Pain; 2011 Dec; 152(12):2852-2860. PubMed ID: 22018972
[TBL] [Abstract][Full Text] [Related]
32. Allosteric Modulation of Muscarinic Acetylcholine Receptors.
Jakubík J; El-Fakahany EE
Pharmaceuticals (Basel); 2010 Aug; 3(9):2838-2860. PubMed ID: 27713379
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
Grant MK; Noetzel MJ; De Lorme KC; Jakubík J; Doležal V; El-Fakahany EE
PLoS One; 2010 Dec; 5(12):e15722. PubMed ID: 21203415
[TBL] [Abstract][Full Text] [Related]
34. Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
Gregory KJ; Hall NE; Tobin AB; Sexton PM; Christopoulos A
J Biol Chem; 2010 Mar; 285(10):7459-74. PubMed ID: 20051519
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.
Noetzel MJ; Grant MK; El-Fakahany EE
Pharmacology; 2009; 83(5):301-17. PubMed ID: 19401618
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
